This is an old revision of the document!
Anuradha Poonepalli
Dr. Anuradha Poonepalli is a pharmaceutical regulatory specialist based in Singapore. She is a consultant in the Health Products Regulation Group of the Health Sciences Authority (HSA).1)
History
Pandemic Preparedness
On January 29-30, 2018, Poonepalli participated as a speaker in a conference titled “DIA and CoRE Conference 2018: Accelerating Access to Innovative Products – Improving Responses to Pandemic Diseases”, hosted by the Drug Information Association (DIA) and the Duke-NUS Centre of Regulatory Excellence (CoRE).2)
COVID-19
Poonepalli participated in a February 11-12, 2020 event titled “2019 novel Coronavirus Global research and innovation forum: towards a research roadmap” co-hosted by the World Health Organization R&D Blueprint and Global Research Collaboration for Infectious Disease Preparedness (GLOPID-R). She and Philip Krause presented on the topic of “Candidate vaccines R&D”.3)
External links
1)
Jasarevic, T. (2020, April 13). Public statement for collaboration on COVID-19 vaccine development. World Health Organization. http://archive.today/2020.10.04-153106/https://www.who.int/news-room/detail/13-04-2020-public-statement-for-collaboration-on-covid-19-vaccine-development
2)
DIA and CoRE Conference 2018: Accelerating Access to Innovative Products – Improving Responses to Pandemic Diseases. Duke-NuS Medical School. Retrieved August 11, 2018, from http://archive.today/2018.08.11-154129/https://www.duke-nus.edu.sg/core/event/dia-and-core-conference-2018-accelerating-access-innovative-products-%E2%80%93-improving-responses
3)
2019 novel Coronavirus Global research and innovation forum: towards a research roadmap AGENDA. (2020). GLOPID-R. https://web.archive.org/web/20230208185417/https://www.glopid-r.org/wp-content/uploads/2020/02/covid-19-global-research-and-innovation-forum-2020-program.pdf